Thierry Kamtchoua

Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults

Thierry Kamtchoua, Monica Bologa, Robert Hopfer et al. · Vaccine · 2012 · 97 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

Safety and immunogenicity of pneumococcal protein vaccine candidates: Monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA–pneumococcal histidine triad protein D vaccine

Monica Bologa, Thierry Kamtchoua, Robert Hopfer et al. · Vaccine · 2012 · 78 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults

Michael Seiberling, Monica Bologa, Roger H. Brookes et al. · Vaccine · 2012 · 72 citations

Veterinary Medicine, Immunology, Infectious Diseases +10

Tolerability, Safety and Pharmacokinetics of the FGLL Peptide, a Novel Mimetic of Neural Cell Adhesion Molecule, Following Intranasal Administration in Healthy Volunteers

Ravi Anand, Michael Seiberling, Thierry Kamtchoua et al. · Clinical Pharmacokinetics · 2007 · 32 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Humoral immunity and delayed-type hypersensitivity in healthy subjects treated for 30days with MK-7123, a selective CXCR2 antagonist

Michael Seiberling, Thierry Kamtchoua, Paul Stryszak et al. · International Immunopharmacology · 2013 · 12 citations

Life Sciences, Immunology, Pharmacology +14